Patents by Inventor Shu-Jean Tsai

Shu-Jean Tsai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070031889
    Abstract: The present invention relates to a method for rapidly detecting quinolone-resistant Salmonella spp. The invention also relates to the oligonucleotide primers and probes utilized in the method, which can differentiate mutant strains having one or two single point mutations in gyrA gene or single point mutation in parC gene from wild type strains, respectively. Said primers and probes can be effectively used for detection of nalidixic acid-resistant and/or ciprofloxacin-resistant Salmonella strains.
    Type: Application
    Filed: October 18, 2006
    Publication date: February 8, 2007
    Applicant: Bureau of Food and Drug Analysis, Department of Health, Executive Yuan
    Inventors: Shu-Jean Tsai, Shu-Wan Wang, Daniel Shih
  • Publication number: 20060035241
    Abstract: The present invention relates to a method for rapidly detecting quinolone-resistant Salmonella spp. The invention also relates to the oligonucleotide primers and probes utilized in the method, which can differentiate mutant strains having one or two single point mutations in gyrA gene or single point mutation in parC gene from wild type strains, respectively. Said primers and probes can be effectively used for detection of nalidixic acid-resistant and/or ciprofloxacin-resistant Salmonella strains.
    Type: Application
    Filed: December 20, 2004
    Publication date: February 16, 2006
    Applicant: Bureau of Food and Drug Analysis, Department of Health, Executive Yuan
    Inventors: Shu-Jean Tsai, Shu-Wan Wang, Daniel Shih
  • Patent number: 5922375
    Abstract: Disclosed herein is a Bifidobacterium strain isolate that is incorporated into food, beverages, animal feeds, and/or dietary supplements. It can be used to provide a healthful bacteria to human adults and non-human mammals. The bacterium acts as a probiotic. For example, the bacterium assists newborns in producing protective acetic acid and lactic acid, as well as antimicrobials and vitamins. The bacterium can also be used to reseed bacteria levels caused by diarrhea, chemotherapy, advancing age, antibiotics, or other causes.
    Type: Grant
    Filed: November 25, 1998
    Date of Patent: July 13, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: John B. Luchansky, Shu-Jean Tsai
  • Patent number: 5902743
    Abstract: Disclosed herein is a Bifidobacterium strain isolate. It can be used as an additive to infant food and beverage products, as well as to provide a healthful bacteria to human adults and non-human mammals. The bacterium acts as a probiotic. For example, the bacterium assists newborns in producing protective acetic acid and lactic acid, as well as antimicrobials and vitamins. The bacterium can also be used to reseed bacteria levels caused by diarrhea, chemotherapy, advancing age, antibiotics, or other causes.
    Type: Grant
    Filed: March 20, 1998
    Date of Patent: May 11, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: John B. Luchansky, Shu-Jean Tsai